NCT04407000View on ClinicalTrials.gov

Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 23, 2020

Primary Completion Date

July 20, 2020

Study Completion Date

August 8, 2020

Conditions
Bioequivalence
Interventions
DRUG

Test: Favipiravir 200 mg (LOQULAR)

Test Drug

DRUG

Reference: Favipiravir 200 mg (Avigan)

Reference Drug

Trial Locations (2)

27000

Farmagen Ar-Ge Biyot. Ltd. Sti., Şahinbey

06970

Novagenix Drug R&D Center, Akyurt

All Listed Sponsors
collaborator

Novagenix Bioanalytical Drug R&D Center

NETWORK

collaborator

Farmagen Ar-Ge Biyot. Ltd. Sti

NETWORK

lead

World Medicine ILAC SAN. ve TIC. A.S.

INDUSTRY

NCT04407000 - Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions | Biotech Hunter | Biotech Hunter